Immediate haploidentical TCRab/CD19 depleted HSCT confers protective immunity to overcome neonatal neutropenia and lymphopenia quickly in a disease which has proven poor outcome in symptomatic children even if they receive alloSCT [4]. This evidence concerns the gene CD19 and neutropenia.